Clinical studies recruiting near Cholet

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Centre Hospitalier de Cholet · Pfizer · NCT06758401 Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic C
Phase 2 · Centre Hospitalier de Cholet · UNICANCER · NCT06245356 Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · Centre Hospitalier · Federation Francophone de Cancerologie Digestive · NCT07270991 A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulc
Phase 4 · Centre hospitalier de Cholet · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT04183608 To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemothe
NA · CH Cholet · Institut Cancerologie de l'Ouest · NCT06800989 Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Me
Phase N/A · Ch - Centre Hospitalier de Cholet · Federation Francophone de Cancerologie Digestive · NCT06353854 Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metast
NA · Centre Hospitalier · Federation Francophone de Cancerologie Digestive · NCT07124858 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · Centre Hospitalier de Cholet · Eli Lilly and Company · NCT07219173 Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
Phase 3 · Réanimation polyvalente et Unité de surveillance continue - · Assistance Publique - Hôpitaux de Paris · NCT05696093 NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia
Phase N/A · Hospital Center · University Hospital, Angers · NCT06238050 Met Non Small Cell Cancer Registry (MOMENT)
Phase N/A · Centre Hospitalier de Cholet · EMD Serono Research & Development Institute, Inc. · NCT05376891 First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Phase 2 · Centre Hospitalier de Cholet · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT06253611 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Centre Hospitalier (Ch) De Cholet · OSE Immunotherapeutics · NCT06472245 Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
NA · Intensive care, University Hospital, Cholet · University Hospital, Tours · NCT06104956 Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
NA · CH Cholet · Centre Hospitalier le Mans · NCT05486884 Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CA
NA · Ch Cholet · University Hospital, Angers · NCT04942080 Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities
NA · CH de Cholet · Nantes University Hospital · NCT06581939 Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
Phase 3 · Centre Hospitalier de Cholet · Gustave Roussy, Cancer Campus, Grand Paris · NCT05692999 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 Acceleration Time Assessment for Prediction of Critical Limb Ischemia
Phase N/A · Centre Hospitalier de CHOLET · Centre Hospitalier le Mans · NCT06296576 Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06813911 Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poo
Phase 3 · Centre Hospitalier de Cholet · ARCAGY/ GINECO GROUP · NCT06476184 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951 Clonal Architecture of ASXL1-mutated Myelofibrosis
NA · CH Cholet · University Hospital, Angers · NCT05710211 Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke
NA · CH Cholet · University Hospital, Angers · NCT07065929 Cannabinoid Hyperemesis Syndrome. Prospective Multicenter Study of Patients Admitted to Adult Emergency Departments in M
Phase N/A · Centre Hospitalier de Cholet · University Hospital, Angers · NCT06660901 French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
Phase N/A · Investigational Site Number: 2500020 · Sanofi · NCT06837454 VRFR- Immersive Virtual Reality Use in a Spine Functional Restoration Program - A Feasibility Study
NA · CH Cholet · University Hospital, Angers · NCT06724679 RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Phase 3 · Cholet Hospital, Emergency department · University Hospital, Angers · NCT06195540 Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Phase 2 · Centre Hospitalier de Cholet · ARCAGY/ GINECO GROUP · NCT05183984

Look up another city

Look up another condition